Cost-effectiveness of nationwide hepatit
โ
David W. Hutton; Samuel K. So; Margaret L. Brandeau
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 308 KB
Liver disease and liver cancer associated with childhood-acquired chronic hepatitis B are leading causes of death among adults in China. Despite expanded newborn hepatitis B vaccination programs, approximately 20% of children under age 5 years and 40% of children aged 5 to 19 years remain unprotecte